Kristin Yarema Net Worth & Insider Trades

Kristin Yarema - Chief Commercial Officer, Atara Biotherapeutics, Inc

As of March 3, 2022

What is Kristin Yarema's Net Worth?

The current estimated net worth of Atara Biotherapeutics, Inc's Chief Commercial Officer, Kristin Yarema, is estimated to be about $745.35K . Kristin Yarema owns about 125,882 units of Atara Biotherapeutics, Inc common stock. In the last 2 years at Atara Biotherapeutics, Inc, Kristin Yarema has sold an estimated value of $11.07K worth.

What is Kristin Yarema's Past Insider Trading?

Kristin Yarema's largest purchase order was 34,354 units , worth over $500.37K on June 15, 2021. Kristin Yarema's largest sale order was 761 units , worth over $11.07K on May 20, 2021. In total, Kristin Yarema has made about 6 transactions over 2 years of their time at Atara Biotherapeutics, Inc. Kristin Yarema usually trades in March, with the busiest year in 2021.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Kristin Yarema

Date Range: All Time
Price per Share
Filing Date
No matching records found


Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What was Kristin Yarema's Salary in 2020?

As Chief Commercial Officer of Atara Biotherapeutics, Inc, Kristin Yarema has a total base salary of $368,308 . Kristin Yarema received compensation valued at about $2,436,407 in 2020 after becoming Chief Commercial Officer. The vast majority of their compensation came in the form of a bonus of $147,995 , stock awards of $668,250 , option awards of $1,067,484 , and other compensation of $184,370 .

What is Kristin Yarema's' Mailing Address?

  • Mailing address is C/o Atara Biotherapeutics, Inc. 611 Gateway Blvd., Suite 900 South San Francisco CA 94080 CA

Atara Biotherapeutics, Inc Executive Compensation

Stock Awards
Option Awards
Other Compensation
Pascal Touchon, D.V.M. 2020 $654,857 $422,500 $2,235,600 $1,959,208 $13,662 $5,285,827
Pascal Touchon, D.V.M. 2019 $319,327 $334,791 $2,861,712 $3,049,718 $71,760 $6,637,307
Jakob Dupont, M.D. 2020 $319,231 $143,346 $443,075 $1,757,296 $133,297 $2,796,245
Utpal Koppikar 2020 $460,947 $187,032 $885,431 $597,073 $7,470 $2,137,953
Utpal Koppikar 2019 $439,875 $155,606 $1,034,714 $909,080 $895 $2,540,170
Utpal Koppikar 2018 $240,289 $189,771 $1,903,500 $1,886,325 $398 $4,220,282
Joseph Newell 2020 $466,055 $203,435 $1,033,965 $566,713 $895 $2,251,063
Joseph Newell 2019 $390,000 $155,208 $1,240,675 $932,390 $895 $2,719,167
Joseph Newell 2018 $365,000 $155,490 $895,000 $1,060,710 $16,092 $2,492,292
Kristin Yarema, Ph.D. 2020 $368,308 $147,995 $668,250 $1,067,484 $184,370 $2,436,407
No matching records found


What are Atara Biotherapeutics, Inc's Past Insider Trades?

Atara Biotherapeutics, Inc's most recent insider trade came on August 18, 2023 by Eric J Hyllengren who sold 8,186 units worth $13.53K . In the last 9 years, insiders at Atara Biotherapeutics, Inc have sold an estimated value of $73.66M and bought an estimated value of $10.47M worth of shares. Insider trading is most common in February, with the busiest year in 2018. The most active traders at the company are Isaac E Ciechanover, Chief Executive Officer,  Christopher Haqq, EVP,  and Joe Newell, Chief Operations Officer .

Atara Biotherapeutics, Inc. Insider Trades

Date Range: All Time
Insider Names
Price per Share
Filing Date
No matching records found